TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

re: Ann: Rights Issue Closure and Shortfall N... At the time...

  1. senoj
    2,630 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    25/05/11
    10:33
    Post #: 8447548
    re: Ann: Rights Issue Closure and Shortfall N... At the time this CR was announced, investors were invited to oversubscribe so some undersubscription was always likely once the market soured. I think the raising was creditable and I doubt the underwriters will have any difficulty moving stock - they are essentially punting on the results of the EU trials - about a month away. I can't thing why these will be any different to previous trials - so it's a pretty good punt.
    TIS Price at posting: 53.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.